Literature DB >> 10410857

Recent advances in the pathology of cutaneous drug eruptions.

A N Crowson1, C M Magro.   

Abstract

Cutaneous reactions to drug therapy may be of either immunologic or nonimmunologic etiology. It is important that the dermatologist and pathologist be familiar with these types of cutaneous reactions. This article discusses the clinical features, pathogenesis, and histopathology of various cutaneous drug eruptions.

Entities:  

Mesh：

Year:  1999        PMID： 10410857     DOI： 10.1016/s0733-8635(05)70106-6

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  6 in total

Review 1.  My approach to superficial inflammatory dermatoses.

Authors:  K O Alsaad; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

Review 2.  Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Authors:  Lucile Warter; Ramapraba Appanna; Katja Fink
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 3.  T cells in drug allergy.

Authors:  Werner J Pichler
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

Review 4.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

5.  Hyperpigmentation Induced by Combination Therapy With Telmisartan-Hydrochlorothiazide.

Authors:  Rosa Giménez-García
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-11       Impact factor: 3.738

6.  Evaluation of histopathological changes in control biopsies which taken 48 sessions after NBUVB phototherapy for early-stage mycosis fungoides.

Authors:  Ebru Zemheri; Seyma Ozkanli; Ilkin Zindanci; Serkan Senol; Ozge Akbulak; Elvan Turfanda; Mehtap Toprak; Duygu Kosemetin; Abdullah Aydin
Journal:  ScientificWorldJournal       Date:  2012-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.